These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26924088)

  • 1. Heterogeneity Among Liver Cancer--A Hurdle to Optimizing Therapy.
    Birkbak NJ; Andersen JB
    Gastroenterology; 2016 Apr; 150(4):818-21. PubMed ID: 26924088
    [No Abstract]   [Full Text] [Related]  

  • 2. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.
    Xue R; Li R; Guo H; Guo L; Su Z; Ni X; Qi L; Zhang T; Li Q; Zhang Z; Xie XS; Bai F; Zhang N
    Gastroenterology; 2016 Apr; 150(4):998-1008. PubMed ID: 26752112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple β-catenin mutations in hepatocellular lesions arising in Abernethy malformation.
    Sorkin T; Strautnieks S; Foskett P; Peddu P; Thompson RJ; Heaton N; Quaglia A
    Hum Pathol; 2016 Jul; 53():153-8. PubMed ID: 27038679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic heterogeneity: next-generation sequencing enables biomarker identification for hepatocellular carcinoma.
    Ziogas DE; Lykoudis EG; Roukos DH; Glantzounis GK
    Biomark Med; 2017 Jul; 11(7):515-518. PubMed ID: 28699774
    [No Abstract]   [Full Text] [Related]  

  • 5. The germline TP53 mutation c.722 C>T promotes bone and liver tumorigenesis at a young age.
    Osumi T; Miharu M; Fuchimoto Y; Morioka H; Kosaki K; Shimada H
    Pediatr Blood Cancer; 2012 Dec; 59(7):1332-3. PubMed ID: 22887876
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined hepatocellular carcinoma and high grade neuroendocrine carcinoma with EWSR1 gene rearrangement.
    Chuah KL; Pang B; Lim D; Lee CK; Chau CY
    Pathology; 2018 Dec; 50(7):779-782. PubMed ID: 30314647
    [No Abstract]   [Full Text] [Related]  

  • 7. Chromosome 17 allele loss in hepatocellular carcinoma but not in synchronous liver adenoma.
    Ding SF; Jalleh RP; Dooley J; Wood CB; Habib NA
    Eur J Surg Oncol; 1993 Apr; 19(2):195-7. PubMed ID: 8387935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two closely neighboring hepatocellular carcinomas mimicking intrahepatic metastasis are confirmed as double primary tumors by the loss of heterozygosity analysis of microsatellites.
    Zhu Z; Zhu HF; Gu YJ; Cong WM
    Chin Med J (Engl); 2013 Aug; 126(16):3187-9. PubMed ID: 23981636
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of Albumin mRNA in Primary Hepatic Neoplasms and Acinar Cell Carcinoma.
    Ting DT; Deshpande V
    Am J Surg Pathol; 2015 Aug; 39(8):1157-8. PubMed ID: 26171921
    [No Abstract]   [Full Text] [Related]  

  • 10. Is albumin mRNA detection in the diagnosis of hepatocellular carcinoma better than existing markers?
    Yaziji H; Gown AM
    Am J Surg Pathol; 2000 Aug; 24(8):1177-9. PubMed ID: 10935665
    [No Abstract]   [Full Text] [Related]  

  • 11. Growing role of CD40 ligand gene transfer therapy in the management of systemic malignancies besides hepatocellular carcinomas.
    Kapoor S
    J Zhejiang Univ Sci B; 2009 Mar; 10(3):242. PubMed ID: 19283881
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of long non-coding RNA p34822 as a potential plasma biomarker for the diagnosis of hepatocellular carcinoma.
    Wang C; Ren T; Wang K; Zhang S; Liu S; Chen H; Yang P
    Sci China Life Sci; 2017 Sep; 60(9):1047-1050. PubMed ID: 28547580
    [No Abstract]   [Full Text] [Related]  

  • 13. Properly assessing CD133 as a risk factor for poor prognosis in patients with hepatocellular carcinoma after resection.
    Lu HF; Yuan WP; Li M; Huang Q; Liu JP; Li LQ; Zhong JH
    Tumour Biol; 2015 Jul; 36(7):4937-8. PubMed ID: 26025114
    [No Abstract]   [Full Text] [Related]  

  • 14. Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity.
    Shi JY; Xing Q; Duan M; Wang ZC; Yang LX; Zhao YJ; Wang XY; Liu Y; Deng M; Ding ZB; Ke AW; Zhou J; Fan J; Cao Y; Wang J; Xi R; Gao Q
    Oncotarget; 2016 Jan; 7(3):2867-77. PubMed ID: 26672766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma.
    Oda T; Tsuda H; Scarpa A; Sakamoto M; Hirohashi S
    Cancer Res; 1992 Jul; 52(13):3674-8. PubMed ID: 1319827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to the Editor With Regard to the Article Entitled: "Branched Chain In Situ Hybridization for Albumin as a Marker of Hepatocellular Differentiation".
    Terris B; Hergli I; Lin-Marq N; Rubbia-Brandt L
    Am J Surg Pathol; 2015 Aug; 39(8):1156-7. PubMed ID: 26171920
    [No Abstract]   [Full Text] [Related]  

  • 17. Alliance of epigenetic forces for the activation of oncogenic Wnt/β-catenin signaling.
    Bai AH; Cheng AS
    J Gastroenterol Hepatol; 2013 Mar; 28(3):383-5. PubMed ID: 23441716
    [No Abstract]   [Full Text] [Related]  

  • 18. The DNAJB1-PRKACA chimera: Candidate biomarker and therapeutic target for fibrolamellar carcinomas.
    Reid LM; Sethupathy P
    Hepatology; 2016 Feb; 63(2):662-4. PubMed ID: 26505878
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular classification and clonal differentiation of hepatocellular carcinoma: the step forward for patient selection for liver transplantation.
    Gehrau R; Mas V; Archer KJ; Maluf D
    Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):539-52. PubMed ID: 21780900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in the Occurrence and Development of Primary Hepatocellular Carcinoma.
    Xu J; Li J; Zheng TH; Bai L; Liu ZJ
    Adv Clin Exp Med; 2016; 25(5):971-975. PubMed ID: 28028963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.